Alexey Yu. Fedorov

Prof. Dr. Alexey Yu. Fedorov


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Russian Chemical Reviews
Verified
Journal Article
Closed access
Valery N. CharushinValery N. Charushin
Valery N. Charushin
EVEgor Verbitskiy
Egor Verbitskiy
OCOleg N. Chupakhin
Oleg N. Chupakhin
DVD. V. Vorobyeva
D. V. Vorobyeva
PGPavel S. Gribanov
Pavel S. Gribanov
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov
The chemistry of heterocyclic compounds has traditionally been and remains a bright area of chemical science in Russia. This is due to the fact that many heterocycles find the widest application. These compounds are the key structural fragments of most drugs, plant protection agents. Many natural compounds are also derivatives of heterocycles. At present, more than half of the hundreds of millions of known chemical compounds are heterocycles. This collective review is devoted to the achievements of Russian chemists in this field over the last 15–20 years. The review presents the achievements of leading heterocyclists representing both RAS institutes and university science. It is worth noting the wide scope of the review, both in terms of the geography of author teams, covering the whole of our large country, and in terms of the diversity of research areas. Practically all major types of heterocycles are represented in the review. The special attention is focused on the practical applications of heterocycles in the design of new drugs and biologically active compounds, high-energy molecules, materials for organic electronics and photovoltaics, new ligands for coordination chemistry, and many other rapidly developing areas. These practical advances would not be possible without the development of new fundamental transformations in heterocyclic chemistry. Bibliography — 2237 references.

1 January 2020 in Macroheterocycles
Verified
Journal Article
Closed access
Oscar I. KoifmanOscar I. Koifman
Oscar I. Koifman
TATatyana A. Ageeva
Tatyana A. Ageeva
Irina Petrovna  BeletskayaIrina Petrovna Beletskaya
Irina Petrovna Beletskaya
AAAlexei D. Averin
Alexei D. Averin
AYAlexei A. Yakushev
Alexei A. Yakushev
EYElena S. Yurina
Elena S. Yurina

1 June 2002 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
JFJean-Pierre Finet
Jean-Pierre Finet
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov
SCSebastien Combes
Sebastien Combes
GBGerard Boyer
Gerard Boyer
Copper-catalyzed O- and N-arylation reactions involving triarylbismuth diacetates or aryllead triacetates are ligand coupling reactions which were discovered in the eighties independently by Bartons and Dodonovs groups. These reagents lead generally to efficient arylation under mild neutral conditions (room temperature or 40 dgree C, no added basic reagent). Recently, the scope of these main group metal mediated reactions was broadened when Chan and Evans reported that organoboron compounds can be used as the source of the organic aryl ligand. Subsequently, organosiloxanes, organostannanes and diaryliodonium salts proved also to be efficient reagents for these mild copper catalyzed O- and N-arylation reactions. Organoantimony compounds were also used but appeared to be less efficient reagents.

20 May 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IGIuliia Gracheva
Iuliia Gracheva
ESEkaterina Sergeevna Shchegravina
Ekaterina Sergeevna Shchegravina
HSHans-Guenther Schmalz
Hans-Guenther Schmalz
IBIrina P. Beletskaya
Irina P. Beletskaya
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov

13 April 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SCSébastien Combes
Sébastien Combes
PBPascale Barbier
Pascale Barbier
SDSoazig Douillard
Soazig Douillard
AMAnne McLeer-Florin
Anne McLeer-Florin
VBVéronique Bourgarel-Rey
Véronique Bourgarel-Rey
VPVincent Peyrot
Vincent Peyrot

6 January 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BRBrigitt Raux
Brigitt Raux
YVYuliia Voitovich
Yuliia Voitovich
CDCarine Derviaux
Carine Derviaux
ALAdrien Lugari
Adrien Lugari
EREtienne Rebuffet
Etienne Rebuffet
XMXavier Morelli
Xavier Morelli